Work

A Phase II Trial of Tideglusib in Alzheimer's Disease

Year: 2015

Type: article

Study design: Clinical Trial

Source: Journal of Alzheimer s Disease

DOI: 10.3233/jad-141959

Authors: Simon Lovestone, for the ARGO investigators, Mercè Boada, Bruno Dubois, Michael Hüll, Juha O. Rinne, Hans-Jürgen Huppertz, Miguel Calero, María V. Andrés, Belén Gómez-Carrillo, Teresa León, Teodoro del Ser

Institutions: University of Oxford, Fundació ACE, Inserm, Institut du Cerveau, Université Pierre-et-Marie-Curie, University of Turku, Turku University Hospital, Turku PET Centre, Swiss Epilepsy Center, Instituto de Salud Carlos III, Biomedical Research Networking Center on Neurodegenerative Diseases

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute for Health and Care Research

Award: NIHR Senior Investigator Award

OpenAlex ID: W1522284801

FWCI: 17

Cites: 46

Cited by: 562

Related to: 10